The AZNH ETF, known as AstraZeneca PLC ADRhedged, is a meticulously crafted financial instrument tailored for investors seeking focused exposure to the dynamic Health Care sector. This ETF concentrates on the Pharma, Biotech & Life Sciences niche, offering a unique investment opportunity with a strategic emphasis on AstraZeneca PLC's American Depositary Receipts (ADRs). By investing in this ETF, stakeholders gain access to a curated selection of securities that represent a significant player in the pharmaceutical and biotechnology industries. Designed to mitigate currency risk, the ADRhedged feature ensures that investors can focus on the potential growth and innovation within the health care sector without the added volatility of foreign exchange fluctuations. This ETF is ideal for those looking to deepen their portfolio with targeted investments in cutting-edge health care advancements, driven by AstraZeneca's robust research and development pipeline and its commitment to addressing global health challenges.
AstraZeneca PLC ADRhedged (AZNH) Fund Flow Chart
AstraZeneca PLC ADRhedged (AZNH) 1 year Net Flows: $0
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.